Search Results 21-30 of 16474 for Proto-oncogene
Thorland EC, Myers SL, Gostout BS, Smith DI. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene. 2003 Feb 27; 22( ...
Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation analyses to assure that the derived models ...
Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer. Histol Histopathol. 2017 Jul; 32 (7):687-698 Epub ...
While PKD1 mediates cell proliferation and also acts as a suppressor of breast tumor cell invasion, PKD3, when expressed, mediates all oncogenic functions.
Guidance for molecular targeted therapy will involve gene analysis of oncogenes and tumor suppressor genes. Results from these studies may provide the ...
Cells with increased oncogene activity adopt a secretory phenotype. For example, increased levels of c-Src not only inhibit differentiation but also induce ...
Mayo Clinic researchers have made advances in neuroscience discoveries including glioblastoma, an aggressive type of brain cancer, and CSF1R-Related ...
Dr. Ji's team developed experimental systems that specifically target oncogenes and tumor suppressors in the cells of interest. These systems can be used to ...
In her Molecular Mechanisms of Tumorigenesis Lab at Mayo Clinic, Verline Justilien, Ph.D., hopes to identify oncogenic drivers of lung cancer and pancreas ...
It's most often used to treat cancers that affect blood cells, such as certain types of leukemia, lymphoma and multiple myeloma. CAR-T cell therapy stands for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.